STRS Ohio’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-500
Closed -$12K 2034
2022
Q2
$12K Sell
500
-8,000
-94% -$192K ﹤0.01% 1988
2022
Q1
$329K Sell
8,500
-4,000
-32% -$155K ﹤0.01% 1573
2021
Q4
$731K Sell
12,500
-5,300
-30% -$310K ﹤0.01% 1331
2021
Q3
$1.06M Hold
17,800
﹤0.01% 1069
2021
Q2
$1.54M Buy
17,800
+2,000
+13% +$173K 0.01% 885
2021
Q1
$1.3M Buy
15,800
+4,800
+44% +$396K ﹤0.01% 990
2020
Q4
$1M Buy
11,000
+5,800
+112% +$527K ﹤0.01% 1059
2020
Q3
$207K Buy
5,200
+2,500
+93% +$99.5K ﹤0.01% 1657
2020
Q2
$92K Buy
+2,700
New +$92K ﹤0.01% 1808
2020
Q1
Sell
-80,000
Closed -$1.57M 2044
2019
Q4
$1.57M Hold
80,000
0.01% 712
2019
Q3
$1.24M Hold
80,000
0.01% 742
2019
Q2
$1.62M Hold
80,000
0.01% 687
2019
Q1
$1.41M Hold
80,000
0.01% 726
2018
Q4
$1.03M Sell
80,000
-1,200
-1% -$15.4K 0.01% 775
2018
Q3
$1.32M Hold
81,200
0.01% 763
2018
Q2
$920K Buy
81,200
+70,100
+632% +$794K ﹤0.01% 938
2018
Q1
$108K Hold
11,100
﹤0.01% 1588
2017
Q4
$67K Hold
11,100
﹤0.01% 1697
2017
Q3
$43K Hold
11,100
﹤0.01% 1805
2017
Q2
$35K Buy
+11,100
New +$35K ﹤0.01% 1843